The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock
Open accessAbstract
Introduction: Altered pharmacokinetics (PK) in critically ill patients can result in insufficient serum β-lactam concentrations when standard dosages are administered. Previous studies on β-lactam PK have generally excluded the most severely ill patients, or were conducted during the steady-state period of treatment. The aim of our study was to determine whether the first dose of piperacillin-tazobactam, ceftazidime, cefepime, and meropenem would result in adequate serum drug concentrations in patients with severe sepsis and septic shock. Methods: Open, prospective, multicenter study in four Belgian intensive care units. All consecutive patients with a diagnosis of severe sepsis or septic shock, in whom treatment with the study drugs was indicated, were included. Serum concentrations of the antibiotics were determined by high-pressure liquid chromatography (HPLC) before and 1, 1.5, 4.5 and 6 or 8 hours after administration. Results: 80 patients were treated with piperacillin-tazobactam (n = 27), ceftazidime (n = 18), cefepime (n = 19) or meropenem (n = 16). Serum concentrations remained above 4 times the minimal inhibitory concentration (T > 4 × MIC), corresponding to the clinical breakpoint for Pseudomonas aeruginosa defined by the European Committee on Antimicrobial Susceptibility Testing (EUCAST), for 57% of the dosage interval for meropenem (target MIC = 8 μg/mL), 45% for ceftazidime (MIC = 32 μg/mL), 34% for cefepime (MIC = 32 μg/mL), and 33% for piperacillin-tazobactam (MIC = 64 μg/mL). The number of patients who attained the target PK profile was 12/16 for meropenem (75%), 5/18 for ceftazidime (28%), 3/19 (16%) for cefepime, and 12/27 (44%) for piperacillin-tazobactam. Conclusions: Serum concentrations of the antibiotic after the first dose were acceptable only for meropenem. Standard dosage regimens for piperacillin-tazobactam, ceftazidime and cefepime may, therefore, be insufficient to empirically cover less susceptible pathogens in the early phase of severe sepsis and septic shock.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Self-citationDellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Self-citationAPACHE II: a severity of disease classification system.
Knaus, W. A., Draper, E. S., Wagner, D. P., & Zimmerman, J. E. (1985) · PubMed · Cited by 6,034
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., & Ramsay, G. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000050454.01978.3b · Cited by 5,995
Self-citationSepsis in European intensive care units: Results of the SOAP study*
Vincent, J.-L., Sakr, Y., Sprung, C. L., Ranieri, V. M., Reinhart, K., Gerlach, H., Moreno, R., Carlet, J., Le Gall, J.-R., & Payen, D. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000194725.48928.3a · Cited by 2,836
Self-citationInadequate Antimicrobial Treatment of Infections
Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest · doi:10.1378/chest.115.2.462 · Cited by 1,805
Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'
Drusano, G. L. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro862 · Cited by 930
Pharmacokinetic issues for antibiotics in the critically ill patient
Roberts, J. A., & Lipman, J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181961bff · Cited by 862
The Pharmacodynamics of β‐Lactams
Turnidge, J. D. (1998) · Clinical Infectious Diseases · doi:10.1086/514622 · Cited by 593
Lodise, T. P., Lomaestro, B., & Drusano, G. L. (2007) · Clinical Infectious Diseases · doi:10.1086/510590 · Cited by 527
McKinnon, P. S., Paladino, J. A., & Schentag, J. J. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.12.009 · Cited by 464
Pea, F., Viale, P., & Furlanut, M. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544100-00002 · Cited by 327
Pharmacodynamics of cefepime in patients with Gram-negative infections
Tam, V. H. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf130 · Cited by 262
Andes, D., & Craig, W. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2375 · Cited by 254
Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections
Craig, W. A., Redington, J., & Ebert, S. C. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.suppl_c.29 · Cited by 238
Zaragoza, R., Artero, A., Camarena, J. J., Sancho, S., González, R., & Nogueira, J. M. (2003) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2003.00656.x · Cited by 211
Roberts, J. A., Kirkpatrick, C. M. J., Roberts, M. S., Dalley, A. J., & Lipman, J. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.10.008 · Cited by 188
Roberts, J. A., Roberts, M. S., Robertson, T. A., Dalley, A. J., & Lipman, J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181968e44 · Cited by 183
Shorr, A. F. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819ced02 · Cited by 181
Benko, A. S., Cappelletty, D. M., Kruse, J. A., & Rybak, M. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.3.691 · Cited by 162
Jaruratanasirikul, S., Sriwiriyajan, S., & Punyo, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1337-1339.2005 · Cited by 149
Pharmacological Principles of Antibiotic Prescription in the Critically Ill
Pinder, M., Bellomo, R., & Lipman, J. (2002) · Anaesthesia and Intensive Care · doi:10.1177/0310057x0203000203 · Cited by 135
Gentamicin volume of distribution in critically ill septic patients
Triginer, C., Izquierdo, I., Fernández, R., Rello, J., Torrent-Farnell, J., Benito, S., & Net, A. (1990) · Intensive Care Medicine · doi:10.1007/bf01706354 · Cited by 128
Continuous infusion versus intermittent administration of meropenem in critically ill patients
Thalhammer, F., Traunmüller, F., Menyawi, I. E., Frass, M., Hollenstein, U., Locker, G. J., Stoiser, B., Staudinger, T., Thalhammer-Scherrer, R., & Burgmann, H. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.4.523 · Cited by 125
Scaglione, F., & Paraboni, L. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.03.015 · Cited by 118
Angus, B., Smith, M. D., Suputtamongkol, Y., Mattie, H., Walsh, A. L., Wuthiekanun, V., Chaowagul, W., & White, N. J. (2000) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2000.00179.x · Cited by 114
Lipman, J., Wallis, S. C., & Rickard, C. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2559 · Cited by 114
Bhat, S. V., Peleg, A. Y., Lodise, T. P., Shutt, K. A., Capitano, B., Potoski, B. A., & Paterson, D. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01487-06 · Cited by 111
Tam, V. H., Gamez, E. A., Weston, J. S., Gerard, L. N., LaRocco, M., Caeiro, J. P., Gentry, L. O., & Garey, K. W. (2008) · Clinical Infectious Diseases · doi:10.1086/528712 · Cited by 110
Continuous infusion ceftazidime in intensive care: a randomized controlled trial
Lipman, J., Gomersall, C. D., Gin, T., Joynt, G. M., & Young, R. J. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.2.309 · Cited by 107
Pharmacokinetics and pharmacodynamics of meropenem in critically ill patients
Kitzes‐Cohen, R., Farin, D., Piva, G., & Myttenaere-Bursztein, S. A. D. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00474-5 · Cited by 97
Intermittent bolus dosing of ceftazidime in critically ill patients
Young, R. P., Lipman, J., Gin, T., Gomersall, C. D., Joynt, G. M., & Oh, T. E. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.2.269 · Cited by 90
Pharmacokinetics of piperacillin–tazobactam: intermittent dosing versus continuous infusion
Buck, C., Bertram, N., Ackermann, T., Sauerbruch, T., Derendorf, H., & Paar, W. D. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.08.012 · Cited by 86
Pitfalls of using estimations of glomerular filtration rate in an intensive care population
Martin, J. H., Fay, M. F., Udy, A. A., Roberts, J. A., Kirkpatrick, C. M. J., Ungerer, J. P. J., & Lipman, J. (2010) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2009.02160.x · Cited by 84
Lorente, L., Jiménez, A., Palmero, S., Jiménez, J. J., Iribarren, J. L., Santana, M. C., Martin, M. M. I. D. O., & Mora, M. L. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.11.003 · Cited by 80
Old antibiotics for infections in critically ill patients
Falagas, M. E., & Kopterides, P. (2007) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32827851d7 · Cited by 77
Boselli, E., Breilh, D., Cannesson, M. P., Xuereb, F., Rimmele, T. R., CHASSARD, D., Saux, M., & Allaouchiche, B. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2222-8 · Cited by 77
Meropenem pharmacokinetics and penetration into an inflammatory exudate
Wise, R. A., Logan, M., Cooper, M., Ashby, J. P., & Andrews, J. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.8.1515 · Cited by 55
Sun, H. K., Kuti, J. L., & Nicolau, D. P. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000181528.88571.9b · Cited by 54
Classification, Incidence, and Outcomes of Sepsis and Multiple Organ Failure
Vincent, J., Taccone, F., & Schmit, X. (2007) · KARGER eBooks · doi:10.1159/000102071 · Cited by 50
Self-citationWilliamson, R., & Tomasz, A. (1985) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1985.tb09126.x · Cited by 50
Delattre, I., Musuamba, F. T., Verbeeck, R. K., Dugernier, T., Spapen, H. D., Laterre, P., Wittebole, X., Cumps, J., Taccone, F. S., Vincent, J., et al. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.12.007 · Cited by 25
Self-citationZeitlinger, M. A., Erović, B. M., Sauermann, R., Georgopoulos, A., Müller, M., & Joukhadar, C. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki284 · Cited by 22
Effectiveness of Cephalosporins in the Sputum of Patients with Nosocomial Bronchopneumonia
Klekner, Á., Bágyi, K., Bognár, L., Gáspár, A., Andrási, M., & Szabó, J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00893-06 · Cited by 21
Maglio, D., Kuti, J. L., & Nicolau, D. P. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.07.004 · Cited by 19
Meropenem pharmacokinetics and pharmacodynamics in patients with ventilator-associated pneumonia
de Stoppelaar, F. M. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.1.150 · Cited by 19
Cited by
The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection
Mazuski, J. E., Tessier, J. M., May, A. K., Sawyer, R. G., Nadler, E. P., Rosengart, M. R., Chang, P. K., O'Neill, P. J., Mollen, K. P., Huston, J. M., et al. (2017) · Surgical Infections · doi:10.1089/sur.2016.261 · Cited by 573
Guilhaumou, R., Benaboud, S., Bennis, Y., Dahyot-Fizelier, C., Dailly, E., Gandia, P., Goutelle, S., Lefeuvre, S., Mongardon, N., Roger, C., et al. (2019) · Critical Care · doi:10.1186/s13054-019-2378-9 · Cited by 543
Blot, S. I., Pea, F., & Lipman, J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.07.006 · Cited by 444
Antibiotics in critically ill patients: A systematic review of the pharmacokinetics of β-lactams.
Gonçalves-Pereira, J., & Póvoa, P. (2011) · Critical Care · doi:10.1186/cc10441 · Cited by 408
Antibiotic stewardship in the intensive care unit
Luyt, C.-E., Bréchot, N., Trouillet, J.-L., & Chastre, J. (2014) · Critical Care · doi:10.1186/s13054-014-0480-6 · Cited by 388
Metadata
- Authors
- Taccone, F. S., Laterre, P.-F., Dugernier, T., Spapen, H., Delattre, I., Wittebole, X., De Backer, D., Layeux, B., Wallemacq, P., Vincent, J.-L., & Jacobs, F.
- Venue
- Critical Care
- Published
- 2010-07-01
- Volume
- 14
- Issue
- 4
- Pages
- R126-R126
- ISSN
- 1364-8535 (ISSN-L)
- OpenAlex
- W1996134595
- Cited by
- 369
- References
- 49
- FWCI
- 13.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.